After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Palantir’s Q4 revealed a 45% operating margin and 36% revenue growth, but its shares reflect over five years’ growth already.

And as the curiosity around investing in Teslas starts to grow for drivers, one bloke who whips around in a Cybertruck shared ...

A mother whose 12-year-old son died in the Omagh bombing believes the pain of his loss will never ease, a public inquiry has ...

Easing inflation has opened the door for the Reserve Bank of Australia to begin an anticipated brief series of interest rate ...

Nicolas S. Piuzzi, MD, was recognized as the 2025 Kappa Delta Young Investigator Award winner for research showing how leveraging advanced analytics with personalized outcome prediction tools can ...

Criminal Minds star Paget Brewster announced she will be undergoing surgery to repair a fractured elbow she recently suffered ...

Bitcoin’s share of the total crypto market cap briefly spiked to 64.3 on Feb. 3, marking its highest level in nearly four ...

This year's commemoration of World Cancer Day offers a three-year journey to raise awareness about one of the world’s biggest ...

Apple and Twilio are both in solid positions to benefit from the continued advancement of artificial intelligence. Click here ...

TrueFoundry, a leading AI deployment and scaling platform, today announced it raised $19 million in Series A funding, led by Intel Capital. Existing investors Eniac Ventures and Peak XV's Surge ...

and rising infrastructure costs like GPU orchestration and model scaling, which slow innovation and limit the impact of AI. TrueFoundry’s platform tackles these pain points head-on, enabling ...